3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Urinary Bladder Neoplasms
2
Sleep Wake Disorders
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Initiation and Maintenance Disorders
1
Sezary Syndrome
1
Prostate Adenocarcinoma
1
Prostate
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pain
1
Ovarian Neoplasms
1
Interventions
Gemcitabine
7
Cisplatin
5
Ramucirumab
3
Platinum
3
Paclitaxel
3
Docetaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Carboplatin
2
rucaparib
1
pegfilgrastim
1
pazopanib
1
eribulin
1
enzalutamide
1
enfortumab vedotin
1
dehydroftorafur
1
cabozantinib
1
avelumab
1
atezolizumab
1
aflibercept
1
Taxes
1
Surgical Procedures, Operative
1
Sunitinib
1
Standard of Care
1
Specimen Handling
1
Sorafenib
1
Radiotherapy
1
Radiation
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Mitozytrex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urethral Neoplasms
×
Early Intervention, Educational
×
Clear all
No trials found.